Gene · 1031
Papers2,553
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,553
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epstein-Barr Virus History and Pathogenesis. | Viruses | 2023 | 36992423 | PubTator, text mining | PubMed |
| Multiple Metastases of Parathyroid and Papillary Thyroid Carcinoma in a Female Patient Treated with Long-Term Hemodialysis. | J Pers Med | 2023 | 36983729 | PubTator, text mining | PubMed |
| The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted Therapies. | Cancers (Basel) | 2023 | 36980578 | PubTator, text mining | PubMed |
| Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1. | Leukemia | 2023 | 36977823 | PubTator, text mining | PubMed |
| Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers. | Acta Pharm Sin B | 2023 | 36970215 | PubTator, text mining | PubMed |
| CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis. | Hereditas | 2023 | 36964635 | PubTator, text mining | PubMed |
| Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks. | Oncogene | 2023 | 36944729 | PubTator, text mining | PubMed |
| A Meta-Analysis of the Genome-Wide Association Studies on Two Genetically Correlated Phenotypes Suggests Four New Risk Loci for Headaches. | Phenomics | 2023 | 36939796 | PubTator, text mining | PubMed |
| In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma. | Front Oncol | 2023 | 36937401 | PubTator, text mining | PubMed |
| Melatonin as a Harmonizing Factor of Circadian Rhythms, Neuronal Cell Cycle and Neurogenesis: Additional Arguments for Its Therapeutic Use in Alzheimer's Disease. | Curr Neuropharmacol | 2023 | 36918783 | PubTator, text mining | PubMed |
| Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system. | Neurooncol Adv | 2023 | 36915613 | PubTator, text mining | PubMed |
Multiple endocrine neoplasia type 1 familial case in a patient with insulinoma and primary hyperparathyroidism: First report in literature and in the Costa Rican population of the c.1224_1225insGTCC pathogenic variant. | Clin Case Rep | 2023 | 36911651 | PubTator, text mining | PubMed |
| The genetic architecture of human amygdala volumes and their overlap with common brain disorders. | Transl Psychiatry | 2023 | 36906575 | PubTator, text mining | PubMed |
| Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study. | Cancers (Basel) | 2023 | 36900299 | PubTator, text mining | PubMed |
| Novel PRUNE2 Germline Mutations in Aggressive and Benign Parathyroid Neoplasms. | Cancers (Basel) | 2023 | 36900197 | PubTator, text mining | PubMed |
| Medicinal chemistry perspective of pyrido[2,3-d]pyrimidines as anticancer agents. | RSC Adv | 2023 | 36865574 | PubTator, text mining | PubMed |
| Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts. | PLoS One | 2023 | 36857322 | PubTator, text mining | PubMed |
| P16INK4a Regulates ROS-Related Autophagy and CDK4/6-Mediated Proliferation: A New Target of Myocardial Regeneration Therapy. | Oxid Med Cell Longev | 2023 | 36852326 | PubTator, text mining | PubMed |
| Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases. | Viruses | 2023 | 36851782 | PubTator, text mining | PubMed |
| Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia. | Cell Rep | 2023 | 36848231 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1031/papers?page=11